bosentan anhydrous has been researched along with Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weinerth, J; Wiesent, F | 1 |
Audia, S; Berthier, S; Bonnotte, B; Leguy, V; Lorcerie, B; Roch, N; Samson, M | 1 |
Mayes, MD | 1 |
1 review(s) available for bosentan anhydrous and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia
Article | Year |
---|---|
Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
Topics: Antihypertensive Agents; Bosentan; Connective Tissue Diseases; Controlled Clinical Trials as Topic; CREST Syndrome; Endothelin Receptor Antagonists; Endothelins; Humans; Hypertension, Pulmonary; Receptors, Endothelin; Sequence Homology, Amino Acid; Signal Transduction; Sulfonamides | 2003 |
2 other study(ies) available for bosentan anhydrous and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia
Article | Year |
---|---|
[Digital ulcers in systemic sclerosis--an interdisciplinary challenge].
Topics: Angiography; Antihypertensive Agents; Arm; Bosentan; Cooperative Behavior; CREST Syndrome; Endothelin Receptor Antagonists; Fatal Outcome; Fingers; Follow-Up Studies; Hand Dermatoses; Humans; Iloprost; Interdisciplinary Communication; Leg; Male; Middle Aged; Scleroderma, Limited; Skin Ulcer; Sulfonamides; Vasodilator Agents | 2010 |
[Tuberculous tenosynovitis].
Topics: Aged; Anti-Inflammatory Agents; Antihypertensive Agents; Antitubercular Agents; Bosentan; Combined Modality Therapy; CREST Syndrome; Diagnosis, Differential; Female; Hand; Humans; Hypertension, Pulmonary; Opportunistic Infections; Sulfonamides; Tenosynovitis; Tuberculosis, Osteoarticular | 2011 |